As Aetna (AET) Stock Value Rose, Cambridge Financial Group INC Has Cut Position by $117.06 Million

October 13, 2017 - By Clifton Ray

Investors sentiment decreased to 0.69 in Q2 2017. Its down 0.25, from 0.94 in 2017Q1. It dived, as 62 investors sold AET shares while 331 reduced holdings. 76 funds opened positions while 195 raised stakes. 290.06 million shares or 2.18% less from 296.52 million shares in 2017Q1 were reported. 427,276 were reported by Polar Ltd Liability Partnership. Jpmorgan Chase Com holds 5.16 million shares. The Switzerland-based Credit Suisse Ag has invested 0.17% in Aetna Inc (NYSE:AET). Breton Hill Capital Limited has invested 0.17% in Aetna Inc (NYSE:AET). Frontier Inv Mgmt reported 2,282 shares. Yhb Investment owns 2,095 shares. Systematic Mngmt LP invested 0.06% in Aetna Inc (NYSE:AET). Murphy Capital Mngmt accumulated 4,833 shares. First Midwest National Bank & Trust Division owns 16,364 shares for 0.31% of their portfolio. Fifth Third Bancorp, Ohio-based fund reported 1,988 shares. Credit Agricole S A, a France-based fund reported 751,051 shares. 2.55M are held by Ubs Asset Americas. Oak Assocs Oh holds 19,460 shares or 0.22% of its portfolio. Spc accumulated 3,500 shares or 0.14% of the stock. Haverford Trust accumulated 3,164 shares.

Since May 9, 2017, it had 0 buys, and 4 selling transactions for $19.91 million activity. Another trade for 880 shares valued at $125,118 was sold by Coye Molly Joel. Bertolini Mark T also sold $14.58 million worth of Aetna Inc (NYSE:AET) shares. Shares for $1.17 million were sold by Lynch Karen S on Wednesday, June 7.

Cambridge Financial Group Inc decreased its stake in Aetna (AET) by 1.63% based on its latest 2017Q2 regulatory filing with the SEC. Cambridge Financial Group Inc sold 771 shares as the company’s stock rose 12.84% with the market. The institutional investor held 46,483 shares of the medical specialities company at the end of 2017Q2, valued at $7.06B, down from 47,254 at the end of the previous reported quarter. Cambridge Financial Group Inc who had been investing in Aetna for a number of months, seems to be less bullish one the $50.83 billion market cap company. The stock rose 0.04% or $0.07 reaching $153.13. About 2.00M shares traded or 10.50% up from the average. Aetna Inc (NYSE:AET) has risen 28.84% since October 13, 2016 and is uptrending. It has outperformed by 12.14% the S&P500.

Cambridge Financial Group Inc, which manages about $186.99 million US Long portfolio, upped its stake in Target Corp (NYSE:TGT) by 25,453 shares to 101,244 shares, valued at $5.29 billion in 2017Q2, according to the filing. It also increased its holding in Sysco Corp (NYSE:SYY) by 107,753 shares in the quarter, for a total of 219,407 shares, and has risen its stake in Unum (NYSE:UNM).

Analysts expect Aetna Inc (NYSE:AET) to report $2.08 EPS on October, 26.They anticipate $0.01 EPS change or 0.48 % from last quarter’s $2.07 EPS. AET’s profit would be $690.44 million giving it 18.41 P/E if the $2.08 EPS is correct. After having $3.42 EPS previously, Aetna Inc’s analysts see -39.18 % EPS growth.

More recent Aetna Inc (NYSE:AET) news were published by: Seekingalpha.com which released: “Trump to sign executive order today changing aspects of Obamacare” on October 12, 2017. Also Nasdaq.com published the news titled: “Is Aetna Inc. (AET) a Great Stock for Value Investors?” on September 22, 2017. Nasdaq.com‘s news article titled: “Aetna Inc. (AET) Ex-Dividend Date Scheduled for October 11, 2017” with publication date: October 10, 2017 was also an interesting one.

Aetna Inc (NYSE:AET) Ratings Coverage

Among 21 analysts covering Aetna (NYSE:AET), 11 have Buy rating, 0 Sell and 10 Hold. Therefore 52% are positive. Aetna had 47 analyst reports since July 30, 2015 according to SRatingsIntel. As per Friday, May 26, the company rating was maintained by Cowen & Co. As per Friday, November 11, the company rating was upgraded by Credit Suisse. The rating was maintained by Wedbush with “Neutral” on Tuesday, February 2. The stock has “Overweight” rating by JP Morgan on Wednesday, September 16. Morgan Stanley initiated Aetna Inc (NYSE:AET) on Wednesday, June 7 with “Overweight” rating. The company was maintained on Thursday, July 13 by Deutsche Bank. The firm has “Buy” rating by Bank of America given on Thursday, July 30. Argus Research maintained it with “Buy” rating and $185 target in Tuesday, September 12 report. The firm has “Hold” rating given on Friday, January 8 by Jefferies. The rating was downgraded by Wolfe Research on Thursday, July 21 to “Peer Perform”.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.